# Receptos, Inc.: Form D filings

Receptos, Inc., a pharmaceuticals company in San Diego, CA, filed 3 Form D notices with the SEC between 2009 and 2012. The latest, on February 17, 2012, reports $10.8 million sold of a $50 million offering to 11 investors.

Find out what Receptos, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Receptos%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Receptos%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Freceptos-inc-1463729)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Receptos%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Receptos%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Freceptos-inc-1463729)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in California](https://specstream.ai/data/form-d/state/california): 5,891 rows, by operating companies, filed since November 1, 2024, $138.91, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/california
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 10835 ROAD TO THE CURE, SUITE 205, San Diego, CA, 92121
- Phone: (858) 652-5712
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2008
- Revenue range: No Revenues
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1463729

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 17, 2012 | New notice | $50,000,011 | $10,806,610 | $39,193,401 | 11 | Feb 3, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463729/000146372912000002/0001463729-12-000002-index.htm) |
| Nov 23, 2009 | New notice | $20,024,000 | $11,999,999 | $8,024,001 | 6 | Nov 9, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463729/000146372909000008/0001463729-09-000008-index.htm) |
| May 22, 2009 | New notice | $7,673,456 | $7,673,456 | $0 | 14 | May 11, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1463729/000146372909000005/0001463729-09-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Amir Nashat | Director |  |
| Marcus Boehm | Executive Officer |  |
| William Rastetter | Director |  |
| Faheem Hasnain | Executive Officer, Director |  |
| Ed Torres | Director |  |
| Robert Peach | Executive Officer |  |
| Doug Cole | Director |  |
| James Schmidt | Executive Officer |  |
| Chrysa Mineo | Executive Officer |  |
| Kristina Burow | Director |  |
| Sheila Gujrathi | Executive Officer |  |
| Raymond Stevens | Director |  |

## Other pharmaceuticals companies in California that filed recently

- [Anvion Bio, Inc.](https://specstream.ai/data/form-d/company/anvion-bio-inc-2158000) $100,000 · Oct 7, 2026
- [Aqur Biosciences, Inc.](https://specstream.ai/data/form-d/company/aqur-biosciences-inc-2094075) $1.5 million · Sep 18, 2026
- [BTB Therapeutics, Inc.](https://specstream.ai/data/form-d/company/btb-therapeutics-inc-2055053) $8.9 million · Aug 12, 2026

[Every Form D from the week of Feb 13, 2012](https://specstream.ai/data/form-d/week/2012-02-13) · [All recent filings in California](https://specstream.ai/data/form-d/state/california) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Receptos, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).